Anthony Gregg Lapointe insider trades
Open-market stock purchases and sales by Anthony Gregg Lapointe, Unknown at Soligenix, Inc, from SEC Form 4 filings since Jan 1, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +80%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | SNGX Soligenix, Inc | Bought (not open market) | — |
| May 15, 2026 | RIGL Rigel Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $25K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $129K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $154K |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc | Sold (not open market) | $204K |
Companies traded
- SNGX Soligenix, Inc: 1 buy, last Sep 17, 2026
- RIGL Rigel Pharmaceuticals Inc: other filings, last May 15, 2026
- ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026
- CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021
- SCLN Sciclone Pharmaceuticals Inc: other filings, last Oct 13, 2017
- CTYX Cytori Therapeutics, Inc: other filings, last May 22, 2017
- RPTP Raptor Pharmaceutical Corp: other filings, last Oct 25, 2016
- IMUC ImmunoCellular Therapeutics, Ltd: other filings, last Jun 17, 2016
- QCOR Questcor Pharmaceuticals Inc: other filings, last Jan 1, 2010
Get free alerts when Anthony Gregg Lapointe files a new trade →